美国儿童Graves病发病率:2007-2022年门诊保险索赔流行病学分析
本研究基于2007-2022年美国门诊保险索赔数据库,回顾性分析儿童Graves病发病率趋势。共识别3377例新诊断,平均年发病率为3.33/10万,年变化无统计学意义。女性和青少年发病率较高,且女性及青少年调整后年发病率显著增加。
要点
- 儿童Graves病平均年发病率为3.33/10万,16年间无显著年度趋势变化。
- 女性平均年发病率5.04/10万,显著高于男性1.67/10万。
- 青少年(13-17岁)平均年发病率最高达5.72/10万,且调整后年发病率显著增加。
核心结论
- 儿童Graves病发病率在女性和青少年中最高,且这两组人群调整后年发病率显著增加。
- 总体年发病率在2007-2022年间无显著变化。
研究设计与样本
- 回顾性队列研究,使用Merative™ Marketscan®门诊保险索赔数据库2007-2022年数据。
- 通过ICD-9和ICD-10代码识别儿童Graves病新诊断病例。
- 共纳入3377例新诊断儿童Graves病患者。
主要发现
- 平均年发病率为3.33/10万(SD=0.33),年增加0.042/10万(p=0.39)。
- 女性平均年发病率5.04/10万,男性1.67/10万。
- 青少年(13-17岁)平均年发病率5.72/10万,高于其他年龄组。
- 多变量回归显示女性年发病率较男性增加1.69/10万(CI: 0.82-2.56)。
- 青少年调整后年发病率较其他年龄组增加4.92/10万(CI: 3.80-6.04)。
关键数值与推荐
- 保险计划类型、地理区域和城乡状态间年发病率无显著变化。
临床怎么用
- 应关注女性和青少年群体的Graves病筛查与早期识别。
- 需持续监测儿童Graves病发病率趋势以辅助早期诊断和管理。
局限性
- 研究基于保险索赔数据,可能存在诊断编码误差或漏诊。
- 未涵盖无保险或未就诊患者,可能低估真实发病率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Graves' disease is the leading cause of hyperthyroidism in children and adolescents, with recent studies indicating a rising incidence. Epidemiological data on trends and determinants influencing this rise remain limited. This study aims to assess the trends in incidence of pediatric Graves' disease in the United States and stratify incidence patterns based on patient sex, age, geographic region, urban vs. rural setting, and insurance plan type. Methods: This retrospective cohort study utilized the Merative™ Marketscan® outpatient insurance claims database from 2007 to 2022. Pediatric patients diagnosed with Graves' disease were identified using International Classification of Diseases (ICD)-9 and ICD-10 codes. Annual incidence rates were analyzed over the study period to detect temporal trends. Incidence rates were further stratified by demographic variables including sex, age, geographic region, community setting (urban vs. rural), and insurance plan. Statistical methods included chi-square, ANOVA, and linear regression models to identify significant trends and differences across subgroups. Results: 3377 total new diagnoses of pediatric Graves' disease were identified during the 16-year study period. The average annual incidence rate was 3.33 per 100,000 (SD = 0.33), with an annual increase of 0.042 per 100,000 (p = 0.39). Marked differences in average annual incidence rates were observed across sex and age group; female patients exhibited greater average annual incidence rate (5.04 per 100,000) compared with male patients (1.67 per 100,000). Adolescents, patients 13-17 years of age, had the highest average annual incidence rate (5.72 per 100,000) compared with other age groups. On multivariable regression analysis, female patients had a significant increase in annual incidence by 1.69 cases per 100,000 compared with male patients [CI: 0.82-2.56]. Adolescents also saw a significant increase in adjusted annual incidence by 4.92 cases per 100,000 compared with the other age groups [CI: 3.80-6.04]. No significant change in annual incidence rate was observed across insurance plan, geographic region, or rural status. Conclusions: This study quantifies and delineates trends in pediatric Graves' disease incidence in the United States. The greatest average incidence rate was observed among female and adolescent patients. This study underscores the importance of monitoring Graves' disease trends to facilitate early disease detection and management. Further research is needed to elucidate the genetic and environmental factors underlying these epidemiological trends.
引用
- Polkampally S, Halagur AS, Green A, et al. Incidence of Pediatric Graves' Disease in the United States: An Epidemiological Analysis of 2007-2022 Outpatient Insurance Claims. Thyroid. 2025. PMID: 40982291. doi:10.1177/10507256251382559
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。